Back to Journals » OncoTargets and Therapy » Volume 7

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer

Total article views   HTML views PDF downloads Totals
14,705 Dovepress* 11,365+ 3,355 14,720
PubMed Central* 3,340 1,123 4,463
Totals 14,705 4,478 19,183
*Since 5 March 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar